[{"Assets_0_Q3_USD":382109000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-46286000.0,"NetIncomeLoss_1_Q3_USD":-30835000.0,"NetIncomeLoss_3_Q3_USD":-54963000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":28704853.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":27022269.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":28704853.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":27022269.0,"StockholdersEquity_0_Q3_USD":37545000.0,"EarningsPerShareBasic_1_Q3_USD":-1.07,"EarningsPerShareBasic_3_Q3_USD":-2.03,"EarningsPerShareDiluted_1_Q3_USD":-1.07,"EarningsPerShareDiluted_3_Q3_USD":-2.03,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":5175000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":45137000.0,"Ticker":"RETA","CIK":"1358762","name":"REATA PHARMACEUTICALS INC","OfficialName":"Reata Pharmaceuticals Inc. Class A Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1148907684.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181107"}]